{"id":6,"date":"2013-12-17T18:01:43","date_gmt":"2013-12-17T18:01:43","guid":{"rendered":"https:\/\/www.newyorkurologyspecialists.com\/bladder-cancer\/?page_id=6"},"modified":"2023-11-04T02:12:53","modified_gmt":"2023-11-04T02:12:53","slug":"innovations-best-practices","status":"publish","type":"page","link":"https:\/\/www.newyorkurologyspecialists.com\/bladder-cancer\/innovations-best-practices\/","title":{"rendered":"2023: Innovations and Best Practices for Treatment of Bladder Cancer"},"content":{"rendered":"

2023: Innovations and Best Practices for Bladder Cancer Treatment<\/span><\/h1>\n

by Alex Shteynshlyuger MD<\/a><\/strong><\/p>\n

\n

If you have any questions, to schedule a consultation<\/a>, please <\/a>contact us<\/a> or call\/text: 646-663-5515<\/a><\/strong>.  <\/strong><\/p>\n

We have excellent reviews from patients <\/a><\/strong>and their partners.  Information for out-of-state and international patients<\/a>.  <\/strong><\/span><\/p>\n

We offer weekday, weekend, and evening<\/strong> office hours.<\/p>\n

We speak Spanish and Russian languages.<\/p>\n

Our visit costs are affordable<\/a> with or without insurance<\/strong>.  Find out our office hours<\/strong> or directions to our office<\/strong><\/a>.  Virtual video visits<\/a> <\/strong>are available.<\/p>\n

\n

Bladder Cancer Treatment Innovations<\/b><\/span><\/h2>\n

\"Doctor_and_patient_shutterstock_72141595\"<\/a>There are a number of innovations that have led to improved care for patients with bladder cancer.  The most important innovations include the use of mitomycin therapy immediately after resection of bladder tumors and cancers<\/strong>.   Mytomycin is a fairly safe agent and leads to a significant benefit with decreased chances of bladder cancer recurrence.<\/p>\n

For patients with high-risk Ta and T1 disease, a re-resection of the tumor bed leads to improved diagnostic information<\/strong>.<\/p>\n

Another important treatment that has been around for a very long time. Only recently, we understood just how beneficial the treatment with BCG therapy administered in the urinary bladder<\/strong> is for patients with bladder cancer.  BCG treatment is appropriate for patients with high-risk or frequently recurring non-muscle invasive bladder cancer. It significantly decreases the recurrence of bladder cancer, and it seems to decrease the chances of it progressing to invasive disease. It is one of the few treatments for non-invasive bladder cancer that has demonstrated a trend toward improving survival in patients with bladder cancer. Evidence shows that intravesical BCG treatment<\/a> is underused in patients who can benefit from it.<\/p>\n

The use of blue-light cystoscopy<\/a><\/strong> (Photodynamic Diagnosis or PDD) with Cysview (Blue light cystoscopy)<\/strong> improves visualization of bladder cancer and decreases recurrence.  It also minimizes the need for multiple surgeries (TURBT).<\/b><\/p>\n

Finally, for patients with muscle-invasive bladder cancer, neoadjuvant chemotherapy<\/strong> given before radical cystectomy leads to significant improvement in survival from bladder cancer.<\/p>\n

2023 is an exciting year for patients with bladder cancer. It promises improved diagnostic and treatment options for bladder carcinoma<\/a>.  We are on our way to winning the fight against bladder cancer.<\/strong> 
\nWe have excellent reviews from patients <\/a><\/strong>and their partners.  Information for out-of-state and international patients<\/a>.  <\/strong><\/span><\/p>\n

We offer affordable appointment costs for treatment <\/a><\/strong>by a top urologist with or without insurance.<\/strong><\/span>
\n Did you know?<\/strong>  <\/span>Dr. Shteynshlyuger has performed thousands of cystoscopy and transurethral procedures including bladder cancer resection (TUR-BT)<\/b>.<\/p>\n